GAS5 and breast carcinoma: To overcome GAS5 loss of function due to acquired mutations in the GCR response element sequence, Pickard et al. reported the generation of an oligonucleotide that mimic the mutated region sequence on breast cancer cells showing pro-apoptotic activity similar to wild-type GAS5 [151].